European drug launches see worst drop in recent history
European drug launches have fallen 27%, raising concerns about market access and innovation in the pharmaceutical industry.
Exploring the Unseen and Unheard
European drug launches have fallen 27%, raising concerns about market access and innovation in the pharmaceutical industry.
Biodeal Pharma nasal spray has been exempted from DPCO price control for five years, offering more accessibility to patients.
Learn why supplier transparency matters for peptides and how to evaluate scientific information effectively.
Retail prices of drugs are now fixed by India’s NPPA for 34 new medications, impacting consumers and pharmacies alike.
Drug price controls are jeopardizing medical innovation and access to new treatments.
USFDA approval Venetoclax marks a significant milestone for Alembic Pharmaceuticals.
Cancer drug price cap: Discover how recent changes impact pricing for patients and access to medications.
Evonile Pharma acquisition is a strategic step to enhance brand portfolio and market presence. Discover the implications and benefits.
USFDA approval Alembic Pharma brings a new $110M otic suspension to market, ensuring safe treatment options.
Bliss GVS Pharma directors are being proposed. Discover if this is a smart choice for shareholders.